Research, Select, & Monitor Wednesday, May 27, 2020 9:14:33 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  CyberArk vs Medical Labs & Research

CyberArk Software Ltd. provides information technology security solutions. The Company offers services which protect organizational privileged accounts from cyber-attacks. Its products include CyberArk Shared Technology Platform, Privileged Account Security Solution and Sensitive Information Management Solution. The company offers privileged account security solution consists of enterprise password vault, which provides a tool to manage and protect physical, virtual, or cloud-based assets in an organization; privileged session manager that protects IT assets; and application identity manager, which addresses the challenges of hard-coded, embedded credentials, and cryptographic keys being hijacked and exploited by malicious insiders or external cyber attackers. CyberArk Software Ltd. is headquartered in Petach Tikva, Israel.

Most are providers of a broad range of diagnostic testing services to hospitals, patients, physicians, and managed care organizations. These can include magnetic-resonance imaging, gene mapping, hair sample testing, etc. Others in this category engage in contractual medical research to study the side effects of drugs about to come onto the market or conduct their own drug research.
 Totals Company Industry
  Sales: $433.9 Mil $21,556.5 Mil
  Market Cap: $4,062.3 Mil $36,617.3 Mil
  Analysts Recommendation: Buy Strong Buy

 Averages Company Industry
  Historic Revenue: 26.4% 6.2%
  Estimated Revenue: 11.8% 4.4%
  Historic Earnings: 23.1% (.1%)
  Estimated Earnings: (32.4%) (8.8%)
  Stock Price (1 Year): (22.8%) (15.1%)
  Cash per Share: 194.4% 133.7%
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 164.2 51.7
  Price-to-Sales: 9.0 N/A
  Price-to-Book: 6.3 3.1
  Dividend Yield: N/A N/A
  Market Cap: $4,062.3 Mil $5,231.0 Mil
  Net Margin: 13.0% (9.7%)
  Gross Margin: 85.6% 47.6%
  Return on Equity: .1 (.1)
  Return on Assets: .0 (.0)
  Balance Sheet
  Current Ratio: 5.9 2.6
  Quick Ratio: 5.9 2.5
  Cash Ratio: 5.5 1.9
  Debt-to-Equity: 1.3 1.4
  Interest Coverage: N/A 1.9
  Relative-Strength Index: 57.9 N/A

 Other companies in Medical Labs & Research Price Market Cap
  Laboratory Corp. of America Holdings  (LH) $174.86 $16,385.0 Mil
  Quest Diagnostics, Inc.  (DGX) $115.54 $15,221.3 Mil
  SP Plus Corporation  (SP) $22.40 $450.6 Mil
  Rigel Pharmaceuticals Inc.  (RIGL) $2.04 $331.9 Mil
  Enzo Biochem Inc.  (ENZ) $2.98 $137.9 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.